Janus Henderson Group’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
DG
Janus Henderson Group's HCAT Position: Q2 2024 in Review
Janus Henderson Group sold out of Health Catalyst (HCAT) in Q2 2024, closing a stake of 19,777 shares — an estimated $149K sold.
Janus Henderson Group first reported a position in HCAT in Q3 2019 and held it in 18 quarters. The position peaked at $78M in Q2 2021. 161 funds tracked by Wall St. Rank hold HCAT as of Q2 2024.
- Janus Henderson Group reported no remaining Health Catalyst position as of Q2 2024 after selling out during the quarter.
- Janus Henderson Group sold 19,777 Health Catalyst shares in Q2 2024, an estimated $149K.
- Janus Henderson Group first reported a position in Health Catalyst in Q3 2019 and held it in 18 quarters.
- Janus Henderson Group's Health Catalyst position peaked at $78M in Q2 2021.
- 161 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2024.
Based on Janus Henderson Group's 13F filing for Q2 2024, filed 14 Aug 2024.